These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1708406)

  • 1. Alterations of somatostatin and its modulation by levodopa in MPTP-treated mouse brain.
    Asanuma M; Ogawa N; Sora YH; Pongdhana K; Haba K; Mori A
    J Neurol Sci; 1990 Dec; 100(1-2):155-60. PubMed ID: 1708406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin alterations and effects of levodopa administration in the MPTP-treated mouse brain.
    Iwata E; Asanuma M; Kondo Y; Nishibayashi S; Matsuura K; Ogawa N
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):31-8. PubMed ID: 7542537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple quantitative bradykinesia test in MPTP-treated mice.
    Ogawa N; Hirose Y; Ohara S; Ono T; Watanabe Y
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):435-41. PubMed ID: 3878557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin content increases following norepinephrine depletion in frontal cortex of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Mitsuo K; Schwartz JP
    J Neurochem; 1992 Jul; 59(1):267-72. PubMed ID: 1351925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MPTP poisoning on central somatostatin and substance P levels in the mouse.
    Radke JM; Cumming P; Vincent SR
    Eur J Pharmacol; 1987 Jan; 134(1):105-8. PubMed ID: 2435563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ketamine on the cholecystokinin, somatostatin, substance P, and thyrotropin releasing hormone in discrete regions of rat brain.
    Pongdhana K; Ogawa N; Hirose Y; Ono T; Kosaka F; Mori A
    Neurochem Res; 1987 Jan; 12(1):73-7. PubMed ID: 2437471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):129-32. PubMed ID: 3258433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K; Kondo T; Narabayashi H
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?
    Allen JM; Cross AJ; Yeats JC; Ghatei MA; McGregor GP; Close SP; Pay S; Marriott AS; Tyers MB; Crow TJ
    Brain; 1986 Feb; 109 ( Pt 1)():143-57. PubMed ID: 2417654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.
    Bagga P; Chugani AN; Varadarajan KS; Patel AB
    J Neurochem; 2013 Nov; 127(3):365-77. PubMed ID: 23957451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study.
    Yadav SK; Pandey S; Singh B
    J Chem Neuroanat; 2017 Nov; 85():50-59. PubMed ID: 28711564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior.
    Ogawa N; Mizukawa K; Hirose Y; Kajita S; Ohara S; Watanabe Y
    Eur Neurol; 1987; 26 Suppl 1():16-23. PubMed ID: 2884111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice.
    Chalimoniuk M; Langfort J
    Neurochem Int; 2007 May; 50(6):821-33. PubMed ID: 17379358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
    J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Dluzen D; Jain R; Liu B
    J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.
    Alexander GM; Schwartzman RJ; Brainard L; Gordon SW; Grothusen JR
    Brain Res; 1992 Aug; 588(2):261-9. PubMed ID: 1356591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM; Murphy DL
    J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of noradrenaline denervation on MPTP-induced deficits in mice.
    Archer T; Fredriksson A
    J Neural Transm (Vienna); 2006 Sep; 113(9):1119-29. PubMed ID: 16362627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C; Marien M
    Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.